Physician profile

Tarun Dalia

Advanced Heart Failure and Transplant Cardiology · Kansas City, KS

NPI 1700235678

$15,733.54

in general payments reported to CMS, 2019-2025

25 companies · $3,302 in 2025

The $3,302 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).

See the full distribution for Advanced Heart Failure and Transplant Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,301.16
Travel and Lodging$3,152.66
Education$32.27

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $8,884.44 2019-2025 Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,247.02 2020-2025 Lifevest
Astrazeneca Pharmaceuticals LP $731.78 2024-2025 Wainua, Farxiga, Brilinta
Abiomed $708.48 2022-2025 Impella
Impulse Dynamics (USA) INC. $474.06 2023-2025 Optimizer, Optimizer
Medtronic, INC. $466.34 2022-2024 Resolute Onyx, Cobalt Dr Mri Surescan
Boston Scientific Corporation $441.61 2019-2025 Watchman Access System, Avvigo Guidance System
Alnylam Pharmaceuticals INC. $433.27 2022-2025 Amvuttra, Onpattro
Endotronix, INC. $327.20 2022-2025 Cordella Pulomonary Artery Pressure Sensor
Merck Sharp & Dohme LLC $317.13 2023-2025 Verquvo, Capvaxive
Edwards Lifesciences Corporation $284.94 2023-2025 The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System
Amgen INC. $233.23 2020-2025 Repatha
Pfizer INC. $218.27 2023-2025
Sanofi-Aventis U.S. LLC $208.70 2019-2021
Novo Nordisk INC $179.59 2023-2025 Wegovy, Ozempic
Show all 25 companies
CompanyGeneral paymentsYearsTop products
Cvrx, INC. $175.35 2024-2025 Barostim Neo System
Boehringer Ingelheim Pharmaceuticals, INC. $88.26 2024-2025 Jardiance
Ancora Heart, INC. $72.17 2024-2025 Accucinch
Medtronic Vascular, INC. $71.94 2019
Bayer Healthcare Pharmaceuticals INC. $43.69 2024-2025
Kiniksa Pharmaceuticals International, Plc $42.61 2024 Arcalyst
Kiniksa Pharmaceuticals, LTD. $24.95 2023 Arcalyst
Nestle Healthcare Nutrition INC. $21.60 2020
E.R. Squibb & Sons, L.L.C. $21.20 2023 Camzyos
Scpharmaceuticals INC. $15.71 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tarun Dalia

$15,733.54

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $3,302 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).

https://glasscript.com/doctor/2351901/tarun-dalia

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.